In order to participate in the GunBroker Member forums, you must be logged in with your GunBroker.com account. Click the sign-in button at the top right of the forums page to get connected.
What Could They Put in the COVID Vaccine? By Jon Rappoport
kimi
Member Posts: 44,719 ✭✭✭
Tiny, tiny biosensors?
From lexico.com: nanotechnology: “The branch of technology that deals with dimensions and tolerances of less than 100 nanometers, especially the manipulation of individual atoms and molecules.”
Click on the following link for article:
https://www.lewrockwell.com/2020/10/jon-rappoport/what-could-they-put-in-the-covid-vaccine/
What's next?
Comments
Just as the lightening bolt said to the man in rubber shoes; resistance is futile.
Brad Steele
And fiery auto crashes
Some will die in hot pursuit
While sifting through my ashes
Some will fall in love with life
And drink it from a fountain
That is pouring like an avalanche
Coming down the mountain
N4 Pharma pointed out that it is not itself attempting to develop a vaccine for coronavirus, it is purely seeking to show whether Nuvec could work as a delivery system for a vaccine when it is developed.
N4 Pharma’s Nuvec is a silica nanoparticle with elongated silica spikes radiating from the core. N4 Pharma explained that this topography results in a high surface area which subsequently is coated with Polyethylenimine (PEI), resulting in a positively charged surface. N4 said it has been previously demonstrated that oligonucleotides including plasmid DNA and mRNA can be attached to the nanoparticle at high loading capacity. In both in vitro and in vivo test models, the loaded nanoparticle is taken up by cells involved in transfection/transduction processes resulting in the synthesis of foreign proteins and stimulation of the required immunological response.
N4 will test to show if Nuvec is capable of loading the Covid-19 plasmid and transfecting cells with the plasmid in vitro. Assuming successful in vitro transfection, the N4 Pharma plans to undertake a proof of concept in vivo study to show the improved transfection when using Nuvec, compared to not using the delivery system, by measuring the production of the antigenic protein and antibodies generated against the encoded Covid-19 protein.
The Covid-19 DNA plasmid will be licensed from the National Institute for Health (NIH) in the USA and is the same plasmid provided to leading biotech companies and researchers already working on Covid-19 vaccines, N4 Pharma said. The company will appoint an experienced contract research organisation (CRO) that it has worked with previously to undertake the program of studies outlined above.
😳😁
I would like to see the abstract of the study. If they are trying to develop a new delivery system it will be reviewed and tested.
The research groups findings were published this week in the journal Science Translational Medicine.
“In other words, they’ve found a covert way to embed the record of a vaccination directly in a patient’s skin rather than documenting it electronically or on paper — and their low-risk tracking system could greatly simplify the process of maintaining accurate vaccine records, especially on a larger scale.”